Browse news, stories, events, and press items with a focus on fine chemical supply, quality systems, sustainability reporting, and regulatory documentation.
A quality inspector shares a real story about verifying color specifications across multiple batches, the hidden trap of assuming 'primary colors' are simple, and why Lonza's COA approach is a better model.
Read moreAn administrative buyer shares a real-world experience navigating chemical procurement, including a surprising lesson about methanol and why vendor expertise matters more than you think.
Read moreAn honest, experience-based look at how to make safe, smart procurement decisions for hazardous chemicals (like HCl) and critical biologicals (like primary human hepatocytes) under extreme time pressure. Featuring advice for pharma buyers and production managers.
Read moreA practical Q&A covering Lonza's capabilities in pharma and biotech, from rush API orders to navigating tech transfer and the Lonza Shop. Written from the perspective of a specialist who handles emergency delivery requests.
Read moreWhy the same GMP rigor needed for API manufacturing applies to every part of your supply chain—even pool chemicals. An emergency specialist's perspective on Lonza and the cost of cutting corners.
Read moreA procurement insider reveals why the lowest bid for API or cell culture media often leads to costly surprises, and how to use total cost of ownership thinking to make smarter vendor decisions in the pharma supply chain.
Read moreA procurement manager's story about navigating an emergency API supply crisis, choosing between a cheap alternative and Lonza's guaranteed delivery, and why paying extra for certainty saved his company from a major financial disaster.
Read moreA procurement manager breaks down the hidden costs in sourcing APIs, cell culture media, and specialty chemicals. Learn how TCO thinking, GMP compliance, and vendor relationships impact your bottom line—with real examples from Lonza, Arch Chemicals, and more.
Read moreAn honest look at the hidden costs of pharma and biotech procurement, from a buyer who's been on the front lines. We explore the real reasons behind budget blowouts and offer a practical path forward.
Read moreAs an office administrator who manages chemical and pharma material purchasing, I've navigated quotes, compliance documents, and hidden costs with Lonza more times than I can count. This FAQ answers the questions I wish someone had answered for me—from pricing transparency to safety specs on atrazine.
Read more